Probecid (Probenecid)

What Is Probecid and What Is It Used For?

Quick Answer: Probecid (probenecid) is a uricosuric medication used for the long-term management of chronic gout. It works by blocking the reabsorption of uric acid in the kidneys, thereby increasing its excretion and lowering blood uric acid levels to prevent gout flares.

Probecid belongs to a class of drugs known as uricosuric agents. Its active ingredient, probenecid, was first developed in the 1950s and has been a cornerstone of gout management for decades. Unlike newer xanthine oxidase inhibitors such as allopurinol and febuxostat, which reduce uric acid production, probenecid works by enhancing the body's ability to eliminate uric acid through the kidneys. This fundamental difference in mechanism makes Probecid a valuable alternative or adjunctive therapy for patients who cannot tolerate or do not respond adequately to other urate-lowering agents.

Gout is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints and surrounding tissues. These crystals form when blood uric acid levels (serum urate) remain elevated above the saturation threshold of approximately 6.8 mg/dL (405 μmol/L). By consistently lowering serum urate below this threshold — ideally below 6.0 mg/dL (360 μmol/L) as recommended by the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) — Probecid helps dissolve existing urate crystals and prevent the formation of new ones.

It is essential to understand that Probecid treatment must be continuous. If the medication is discontinued, uric acid levels will rise again, potentially triggering new gout attacks and further crystal deposition. Probecid does not have any direct analgesic or anti-inflammatory properties; therefore, during acute gout flares, appropriate anti-inflammatory medications such as NSAIDs, colchicine, or corticosteroids must be used concurrently for symptom relief.

Secondary Use: Penicillin Enhancement

In addition to its primary role in gout management, Probecid has an important secondary application: it inhibits the renal tubular secretion of penicillin and other beta-lactam antibiotics. When administered alongside penicillin, Probecid increases the antibiotic's plasma concentration and extends its duration of action. This pharmacokinetic interaction allows for less frequent dosing of penicillin and can be particularly useful in treating certain infections where sustained high antibiotic levels are required, such as gonorrhea, neurosyphilis, and pelvic inflammatory disease.

The dual utility of probenecid — as both a uricosuric agent and a penicillin enhancer — reflects its action on organic anion transporters in the proximal tubules of the kidneys. By inhibiting these transporters, probenecid reduces the renal clearance of multiple organic anions, including uric acid and various drugs, making it a pharmacologically versatile medication.

What Should You Know Before Taking Probecid?

Quick Answer: Before starting Probecid, your doctor must evaluate your kidney function and medical history. Do not take Probecid if you have severe kidney impairment, a history of uric acid kidney stones, or are allergic to probenecid. Always inform your doctor about all medications you are currently taking.

Probecid requires careful medical evaluation before initiation. Your healthcare provider will typically order blood tests to assess kidney function (creatinine clearance) and baseline uric acid levels, as well as a urinalysis to check for uric acid crystalluria. Patients with a creatinine clearance below 30 mL/min should generally not use probenecid, as its uricosuric effect becomes negligible at reduced glomerular filtration rates. Understanding these prerequisites helps ensure safe and effective therapy.

Contraindications

You should not take Probecid if any of the following apply to you:

• Allergy to probenecid or any other ingredient in the tablet (gelatin, potato starch, colloidal silicon dioxide, stearic acid, talc, or magnesium stearate)
• Severe kidney impairment (creatinine clearance below 30 mL/min) — probenecid is ineffective in advanced renal disease
• History of uric acid kidney stones (nephrolithiasis) — increased uric acid excretion may promote stone formation
• Acute gout attack — do not initiate probenecid during an active flare; wait until the attack has fully resolved
• Overproduction of uric acid — conditions such as myeloproliferative disorders, tumor lysis syndrome, or Lesch-Nyhan syndrome
• Children under 2 years of age

Warnings and Precautions

Additional precautions include monitoring for signs of hypersensitivity reactions, which can manifest as skin rash, itching, or more severe symptoms. Patients with a history of peptic ulcer disease should be monitored, as probenecid may cause gastrointestinal discomfort. Regular blood tests to monitor uric acid levels and kidney function are recommended, especially during the first months of therapy.

Probenecid should not be initiated during an acute gout attack, as rapid changes in uric acid levels can paradoxically prolong or worsen the flare. Current guidelines from the ACR (2020) and EULAR (2022) recommend that urate-lowering therapy be started either 2 weeks after the acute attack has resolved or, alternatively, during the attack with appropriate anti-inflammatory prophylaxis. Your doctor will determine the optimal timing for your individual situation.

Pregnancy and Breastfeeding

There is limited clinical experience with the use of Probecid during pregnancy. Animal studies have not shown direct harmful effects, but as with all medications, the potential risks and benefits should be carefully weighed. If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before using Probecid. Probenecid crosses the placenta and could theoretically affect fetal uric acid metabolism.

It is unknown whether probenecid is excreted in human breast milk. As a precaution, breastfeeding women should consult their doctor before using Probecid regularly. The decision to continue breastfeeding during probenecid therapy should be made in consultation with your healthcare provider, considering the benefit of breastfeeding to the infant and the benefit of treatment to the mother.

Driving and Operating Machinery

Probecid has no known effect or negligible effect on the ability to drive or operate machinery. No restrictions on driving or operating heavy equipment are necessary while taking this medication.

How Does Probecid Interact with Other Drugs?

Quick Answer: Probecid has significant interactions with several medications, including methotrexate, certain NSAIDs (naproxen, indomethacin, ketorolac), zidovudine, and paracetamol. It also intentionally enhances penicillin levels when used as an adjunct antibiotic therapy.

Probenecid affects drug metabolism and elimination primarily by inhibiting organic anion transporters (OATs) in the renal tubules. This mechanism can significantly alter the pharmacokinetics of co-administered drugs, leading to increased plasma concentrations and potentially enhanced therapeutic or toxic effects. Understanding these interactions is critical for safe prescribing and medication management.

Always inform your doctor and pharmacist about all medications you are currently taking, including prescription drugs, over-the-counter medicines, herbal supplements, and vitamins. The following table summarizes the most clinically important drug interactions with Probecid:

Additional Interaction Considerations

Beyond the drugs listed above, probenecid may interact with other organic anion substrates, including certain cephalosporin antibiotics, acyclovir, famciclovir, and loop diuretics such as furosemide. Probenecid can also interfere with laboratory tests for uric acid and may affect the results of urine dipstick tests for glucose.

Salicylates (including low-dose aspirin) antagonize the uricosuric effect of probenecid. Even low doses of aspirin (75–325 mg daily for cardiovascular prophylaxis) can significantly reduce the effectiveness of probenecid in lowering uric acid levels. If you require antiplatelet therapy, discuss alternative urate-lowering strategies with your doctor.

What Is the Correct Dosage of Probecid?

Quick Answer: For gout, the usual adult dose starts at 250 mg (half a tablet) twice daily during the first week, then increases to 500 mg (one tablet) twice daily. When used with penicillin, the dose is 1000 mg (two tablets) twice daily. Always follow your doctor's individual dosing instructions.

The dosage of Probecid must be determined by your doctor and individually tailored based on your serum urate levels, kidney function, and therapeutic goals. Treatment typically begins at a low dose to minimize the risk of acute gout flares and renal uric acid precipitation, then gradually increases to achieve target uric acid levels. The following dosing recommendations are based on international clinical guidelines.

Adults — Gout Management

Children

Probecid is not recommended for children under 2 years of age. For older children, dosing is based on body weight and must be determined by a pediatrician. The typical pediatric dose for penicillin enhancement is 25 mg/kg as an initial dose, followed by 10 mg/kg four times daily. Probenecid is rarely used for gout in children, as primary gout is extremely uncommon in the pediatric population.

Elderly Patients

Elderly patients may require dose adjustments based on renal function, which typically declines with age. Kidney function should be assessed before initiating therapy and monitored regularly. Start with the lowest effective dose and titrate cautiously. Ensure adequate hydration, as elderly patients are at increased risk of dehydration and subsequent uric acid stone formation.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Consistency is important for maintaining stable uric acid levels, so try to take Probecid at the same times each day.

Overdose

There is no specific antidote for probenecid overdose. Treatment is supportive and symptomatic, with particular attention to maintaining adequate hydration and monitoring kidney function. Activated charcoal may be considered if the overdose is recent and the patient is alert.

What Are the Side Effects of Probecid?

Quick Answer: The most common side effect of Probecid is nausea. Skin rash is rare, and hemolytic anemia has been reported at an unknown frequency. Most patients tolerate Probecid well, and side effects can often be minimized by taking the medication with food and drinking plenty of fluids.

Like all medications, Probecid can cause side effects, although not everyone will experience them. The majority of patients tolerate probenecid well, particularly when it is introduced gradually and taken with adequate food and fluid intake. The following side effects have been documented in clinical studies and post-marketing surveillance:

Managing Side Effects

Most gastrointestinal side effects can be mitigated by taking Probecid with food or after meals. If nausea persists, your doctor may recommend temporarily reducing the dose or splitting the dose into smaller, more frequent administrations. Adequate hydration also helps reduce the incidence of side effects.

During the initial weeks of treatment, some patients may experience an increase in gout attacks. This is a recognized phenomenon known as a “mobilization flare” and occurs because the lowering of serum urate causes existing crystal deposits to begin dissolving, triggering an inflammatory response. Your doctor will likely prescribe prophylactic anti-inflammatory medication (such as low-dose colchicine or an NSAID) for the first 3–6 months of urate-lowering therapy to prevent these flares.

When to Seek Medical Attention

Contact your doctor immediately if you experience any of the following symptoms while taking Probecid:

• Severe skin rash, hives, or signs of allergic reaction (swelling of face, lips, throat)
• Unusual bleeding or bruising
• Extreme fatigue, pale skin, or rapid heartbeat (signs of anemia)
• Severe or persistent abdominal pain
• Blood in the urine or significant flank pain (signs of kidney stones)
• Yellowing of the skin or eyes (jaundice)

How Should You Store Probecid?

Quick Answer: Store Probecid at room temperature (below 25°C / 77°F), in its original packaging, away from moisture and light. Keep out of reach of children. Do not use after the expiration date.

Proper storage of medications ensures their safety and effectiveness throughout their shelf life. Probecid should be stored under the following conditions:

• Temperature: Store at or below 25°C (77°F). Do not freeze.
• Protection: Keep in the original container to protect from moisture and light.
• Accessibility: Store out of sight and reach of children.
• Expiration: Do not use Probecid after the expiration date printed on the packaging. The expiration date refers to the last day of the indicated month.

Do not dispose of medications via the household drain or with general household waste. Return unused or expired medications to your local pharmacy for safe disposal. These measures help protect the environment and prevent accidental ingestion by children or pets.

What Does Probecid Contain?

Quick Answer: Each Probecid tablet contains 500 mg of the active substance probenecid, along with inactive ingredients including gelatin, potato starch, colloidal silicon dioxide, stearic acid, talc, and magnesium stearate.

Active Ingredient

Each tablet contains 500 mg probenecid as the active substance. Probenecid (chemical name: 4-[(dipropylamino)sulfonyl]benzoic acid) is a sulfonamide derivative with uricosuric and renal tubular transport-inhibiting properties.

Inactive Ingredients (Excipients)

The tablet also contains the following inactive ingredients, which serve various pharmaceutical functions:

• Gelatin — binding agent
• Potato starch — disintegrant (helps the tablet break apart in the digestive tract)
• Colloidal silicon dioxide — flow agent (ensures uniform tablet composition)
• Stearic acid — lubricant
• Talc — glidant
• Magnesium stearate — lubricant (prevents the tablet from sticking to manufacturing equipment)

Packaging

Probecid is supplied in a plastic container containing 50 tablets. The packaging is designed to protect the tablets from moisture and light. Always ensure the container is tightly closed after each use.

References & Sources

This article is based on peer-reviewed medical literature, international clinical guidelines, and approved prescribing information. All medical claims adhere to the GRADE evidence framework with Level 1A evidence where available.

1. FitzGerald JD, et al. 2020 American College of Rheumatology Guideline for Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744-760. doi:10.1002/acr.24180
2. Richette P, et al. 2022 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2022;81(S1):24-25. doi:10.1136/annrheumdis-2022-eular.3005
3. Hui M, et al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford). 2017;56(7):e1-e20. doi:10.1093/rheumatology/kex156
4. World Health Organization. WHO Model List of Essential Medicines – 23rd List, 2023. Geneva: WHO; 2023.
5. Cunningham RF, et al. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet. 1981;6(2):135-151.
6. Drug Safety Update. Probenecid: summary of product characteristics. European Medicines Agency reference documentation.
7. Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010;6(1):30-38.
8. Khanna D, et al. 2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis. Arthritis Care Res. 2012;64(10):1447-1461.

Editorial Team

This article has been developed by the iMedic Medical Editorial Team, a multidisciplinary group of licensed healthcare professionals with expertise in rheumatology, clinical pharmacology, and internal medicine. All content undergoes rigorous medical review according to international guidelines and the GRADE evidence framework.